RichardMenendezMD

PubMed

• Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients.
  Liapikou A, Polverino E, Ewig S, Cillóniz C, Marcos MA, Mensa J, Bello S, Martin-Loeches I, Menéndez R, Torres A> ;Eur. Respir. J.. 2012-04-01
• Initial management of pneumonia and sepsis: factors associated with improved outcome.
  Menéndez, R.,Torres, A.,Reyes, S.,Zalacain, R.,Capelastegui, A.,Aspa, J.,Borderías, L.,Martín-Villasclaras, J. J.,Bello, S.,Alfageme, I.,de Castro, F. R.,Rello, J.,Mol...> ;Eur. Respir. J.. 2011 Aug 11
• Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia.
  Moret I, Lorenzo MJ, Sarria B, Cases E, Morcillo E, Perpiñá M, Molina JM, Menéndez R> ;Eur. Respir. J.. 2011-11-01
• Factors associated with inflammatory cytokine patterns in community-acquired pneumonia.
  Martínez R, Menéndez R, Reyes S, Polverino E, Cillóniz C, Martínez A, Esquinas C, Filella X, Ramírez P, Torres A> ;Eur. Respir. J.. 2011-02-01
• Macrophage activation in exacerbated COPD with and without community-acquired pneumonia.
  Gutierrez P, Closa D, Piñer R, Bulbena O, Menéndez R, Torres A> ;Eur. Respir. J.. 2010-08-01
• Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty?
  Torres A, Menéndez R> ;Eur. Respir. J.. 2010-03-01
• Stability in community-acquired pneumonia: one step forward with markers?
  Menéndez, R.,Martinez, R.,Reyes, S.,Mensa, J.,Polverino, E.,Filella, X.,Esquinas, C.,Martinez, A.,Ramirez, P.,Torres, A.> ;Thorax. 2009 Sep 19
• Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia.
  Menéndez, R.,Martínez, R.,Reyes, S.,Mensa, J.,Filella, X.,Marcos, M. A.,Martínez, A.,Esquinas, C.,Ramirez, P.,Torres, A.> ;Thorax. 2009 Jan 10
• Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia.
  Capelastegui A, España PP, Quintana JM, Bilbao A, Menendez R, Zalacain R, Torres A> ;Thorax. 2009-06-01
• The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia.
  Aliberti S, Myers JA, Peyrani P, Blasi F, Menendez R, Rossi P, Cosentini R, Lopardo G, de Vedia L, Ramirez JA> ;Eur. Respir. J.. 2009-01-01
• Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome.
  Dambrava PG, Torres A, Vallès X, Mensa J, Marcos MA, Peñarroja G, Camps M, Estruch R, Sánchez M, Menéndez R, Niederman MS> ;Eur. Respir. J.. 2008-10-01
• Determinants of hospital costs in community-acquired pneumonia.
  Reyes S, Martinez R, Vallés JM, Cases E, Menendez R> ;Eur. Respir. J.. 2008-05-01
• Markers of treatment failure in hospitalised community acquired pneumonia.
  Menéndez, R.,Cavalcanti, M.,Reyes, S.,Mensa, J.,Martinez, R.,Marcos, M. A.,Filella, X.,Niederman, M.,Torres, A.> ;Thorax. 2008 Feb 05
• Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia.
  Ramirez P, Garcia MA, Ferrer M, Aznar J, Valencia M, Sahuquillo JM, Menéndez R, Asenjo MA, Torres A> ;Eur. Respir. J.. 2008-02-01
• Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia.
  Menéndez R, Reyes S, Martínez R, de la Cuadra P, Manuel Vallés J, Vallterra J> ;Eur. Respir. J.. 2007-04-01
• Mortality in COPD patients with community-acquired pneumonia: who is the third partner?
  Torres A, Menéndez R> ;Eur. Respir. J.. 2006-08-01
• Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome.
  Menéndez R, Torres A, Zalacaín R, Aspa J, Martín Villasclaras JJ, Borderías L, Benítez Moya JM, Ruiz-Manzano J, Rodríguez de Castro F, Blanquer J, Pérez D, Puzo C, Sán...> ;Thorax. 2004-11-01
• Duration of length of stay in pneumonia: influence of clinical factors and hospital type.
  Menéndez R, Cremades MJ, Martínez-Moragón E, Soler JJ, Reyes S, Perpiñá M> ;Eur. Respir. J.. 2003-10-01
• Community-acquired pneumonia in the elderly: Spanish multicentre study.
  Zalacain R, Torres A, Celis R, Blanquer J, Aspa J, Esteban L, Menéndez R, Blanquer R, Borderías L> ;Eur. Respir. J.. 2003-02-01
• Initial risk class and length of hospital stay in community-acquired pneumonia.
  Menéndez R, Ferrando D, Vallés JM, Martínez E, Perpiñá M> ;Eur. Respir. J.. 2001-07-01
• Prognostic factors in restoration of pulmonary flow after submassive pulmonary embolism: a multiple regression analysis.
  Menéndez R, Nauffal D, Cremades MJ> ;Eur. Respir. J.. 1998-03-01
• Pulmonary infection with Nocardia species: a report of 10 cases and review.
  Menéndez R, Cordero PJ, Santos M, Gobernado M, Marco V> ;Eur. Respir. J.. 1997-07-01
• Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: a Bayesian analysis.
  Pastor A, Menéndez R, Cremades MJ, Pastor V, Llopis R, Aznar J> ;Eur. Respir. J.. 1997-03-01
• Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study.
  Blanquer J, Blanquer R, Borrás R, Nauffal D, Morales P, Menéndez R, Subías I, Herrero L, Redón J, Pascual J> ;Thorax. 1991-07-01
• Join now to see all